Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 14.51B | 13.50B | 13.03B | 11.93B | 11.00B |
Gross Profit | 3.37B | 2.98B | 2.91B | 2.39B | 1.96B |
EBITDA | 2.88B | 2.44B | 2.35B | 1.86B | 1.55B |
Net Income | 1.51B | 1.29B | 1.26B | 873.00M | 618.22M |
Balance Sheet | |||||
Total Assets | 24.13B | 23.58B | 22.43B | 21.45B | 20.85B |
Cash, Cash Equivalents and Short-Term Investments | 5.64B | 5.78B | 5.43B | 4.80B | 4.48B |
Total Debt | 978.78M | 1.46B | 1.52B | 1.84B | 1.99B |
Total Liabilities | 4.55B | 5.12B | 5.00B | 5.01B | 5.07B |
Stockholders Equity | 19.57B | 18.46B | 17.43B | 16.44B | 15.78B |
Cash Flow | |||||
Free Cash Flow | 1.09B | 1.23B | 1.55B | 792.44M | 1.07B |
Operating Cash Flow | 2.13B | 1.81B | 1.93B | 1.38B | 1.55B |
Investing Cash Flow | -1.19B | -623.58M | -451.59M | -679.18M | -539.98M |
Financing Cash Flow | -1.09B | -830.06M | -771.64M | -462.24M | -853.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥4.85B | 7.22 | 1.75% | 3.62% | 48.23% | ||
78 Outperform | ¥13.14B | 12.70 | 2.51% | 7.20% | 291.22% | ||
78 Outperform | ¥18.74B | 12.38 | 2.37% | 7.43% | 17.74% | ||
71 Outperform | ¥19.37B | 14.24 | 1.21% | -5.25% | -11.55% | ||
71 Outperform | ¥9.07B | 16.45 | 3.52% | 8.60% | 55.62% | ||
66 Neutral | ¥15.44B | 26.70 | 2.92% | -2.57% | -51.75% | ||
58 Neutral | HK$14.28B | 4.69 | -3.01% | 5.60% | 3.67% | -54.16% |